Your browser doesn't support javascript.
loading
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.
Subbiah, V; Kreitman, R J; Wainberg, Z A; Cho, J Y; Schellens, J H M; Soria, J C; Wen, P Y; Zielinski, C C; Cabanillas, M E; Boran, A; Ilankumaran, P; Burgess, P; Romero Salas, T; Keam, B.
Afiliação
  • Subbiah V; The University of Texas MD Anderson Cancer Center, Houston.
  • Kreitman RJ; National Institutes of Health, Bethesda.
  • Wainberg ZA; University of California, Los Angeles, USA.
  • Cho JY; Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea.
  • Schellens JHM; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Soria JC; Institut Gustave Roussy, University of Paris-Sud, and University of Paris-Saclay, Villejuif, France.
  • Wen PY; Dana-Farber Cancer Institute, Boston, USA.
  • Zielinski CC; Medical University of Vienna, Vienna, Austria.
  • Cabanillas ME; The University of Texas MD Anderson Cancer Center, Houston.
  • Boran A; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Ilankumaran P; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Burgess P; Novartis Pharma AG, Basel, Switzerland.
  • Romero Salas T; Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Keam B; Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: bhumsuk@snu.ac.kr.
Ann Oncol ; 33(4): 406-415, 2022 04.
Article em En | MEDLINE | ID: mdl-35026411

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Anaplásico da Tireoide Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Anaplásico da Tireoide Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article